Literature DB >> 18497541

Cytological and cyst fluid analysis of small (< or =3 cm) branch duct intraductal papillary mucinous neoplasms adds value to patient management decisions.

Martha Bishop Pitman1, Paul J Michaels, Vikram Deshpande, William R Brugge, Brenna C Bounds.   

Abstract

BACKGROUND/AIM: Management of patients with small (1-3 cm) branch duct intraductal papillary mucinous neoplasms (IPMN) is a challenge. Symptoms, dilated duct, mural nodule or positive cytology have been proposed as parameters for resection. The aim of our study was to compare this proposed algorithm to one that incorporates cytology with less than malignant epithelial cells and cyst fluid carcinoembryonic antigen (CEA).
METHODS: A retrospective study was conducted.
RESULTS: There were 14 nonmalignant and 6 malignant cysts with 3 invasive IPMN. None were associated with a dilated duct and none had positive cytology. Only a mural nodule was significant by univariate analysis for the detection of malignancy (p = 0.01) and invasion (p = 0.009). The detection of atypical epithelial cells or a cyst fluid CEA of >2,500 ng/ml was more accurate for the detection of malignancy than using the recommended algorithm.
CONCLUSIONS: The presence of a mural nodule in a small branch duct IPMN is a predictor of malignancy and invasion by univariate analysis. Recognition of an atypical epithelial cell component in contrast to positive cytology or a cyst fluid CEA of >2,500 ng/ml is more accurate than the recommended algorithm and adds value to the preoperative assessment of clinically diagnosed small branch duct IPMN. and IAP. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 18497541     DOI: 10.1159/000134276

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  24 in total

Review 1.  Intraductal papillary mucinous neoplasia (IPMN) of the pancreas: its diagnosis, treatment, and prognosis.

Authors:  Robert Grützmann; Stefan Post; Hans Detlev Saeger; Marco Niedergethmann
Journal:  Dtsch Arztebl Int       Date:  2011-11-18       Impact factor: 5.594

Review 2.  IPMN: surgical treatment.

Authors:  Reto M Käppeli; Sascha A Müller; Bianka Hummel; Christina Kruse; Philip Müller; Jürgen Fornaro; Alexander Wilhelm; Marcel Zadnikar; Bruno M Schmied; Ignazio Tarantino
Journal:  Langenbecks Arch Surg       Date:  2013-09-03       Impact factor: 3.445

Review 3.  Endoscopic ultrasound guided fine needle aspiration and useful ancillary methods.

Authors:  Mario Tadic; Tajana Stoos-Veic; Rajko Kusec
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

4.  The value of cyst fluid analysis in the pre-operative evaluation of pancreatic cysts.

Authors:  Martha Bishop Pitman; William R Brugge; Andrew L Warshaw
Journal:  J Gastrointest Oncol       Date:  2011-12

Review 5.  Molecular analysis of cyst fluid aspiration in the diagnosis and risk assessment of cystic lesions of the pancreas.

Authors:  Sagar S Garud; Field F Willingham
Journal:  Clin Transl Sci       Date:  2011-12-08       Impact factor: 4.689

6.  Uncinate duct dilation in intraductal papillary mucinous neoplasms of the pancreas: a radiographic finding with potentially increased malignant potential.

Authors:  John B Ammori; Richard K G Do; Murray F Brennan; Michael I D'Angelica; Ronald P Dematteo; Yuman Fong; William R Jarnagin; Peter J Allen
Journal:  J Gastrointest Surg       Date:  2014-01-22       Impact factor: 3.452

Review 7.  International consensus on the management of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Masao Tanaka
Journal:  Ann Transl Med       Date:  2015-11

8.  Cytology adds value to imaging studies for risk assessment of malignancy in pancreatic mucinous cysts.

Authors:  Muriel Genevay; Mari Mino-Kenudson; Kurt Yaeger; Ioannis T Konstantinidis; Cristina R Ferrone; Sarah Thayer; Carlos Fernandez-del Castillo; Dushyant Sahani; Brenna Bounds; David Forcione; William R Brugge; Martha Bishop Pitman
Journal:  Ann Surg       Date:  2011-12       Impact factor: 12.969

9.  Diagnostic and therapeutic endoscopic approaches to intraductal papillary mucinous neoplasm.

Authors:  Brian G Turner; William R Brugge
Journal:  World J Gastrointest Surg       Date:  2010-10-27

10.  Plectin-1 is a biomarker of malignant pancreatic intraductal papillary mucinous neoplasms.

Authors:  Dirk Bausch; Mari Mino-Kenudson; Carlos Fernández-Del Castillo; Andrew L Warshaw; Kimberly A Kelly; Sarah P Thayer
Journal:  J Gastrointest Surg       Date:  2009-09-17       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.